Taysha Gene Therapies
TSHA
HK$20.57
Share price
-1.87%
Change (1 day)
14.95%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total assets
Total assets on the balance sheet as of March 2025 : HK$1.08 Billion
According to Taysha Gene Therapies's latest financial reports the company's total assets are HK$1.08 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Taysha Gene Therapies - Total assets on balance sheet (from 2020 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | HK$1.24 B | -7.71% |
| 2023-12-31 | HK$1.34 B | 36.73% |
| 2022-12-31 | HK$0.98 B | -40.86% |
| 2021-12-31 | HK$1.66 B | -16.87% |
| 2020-12-31 | HK$2.00 B | 1717813.39% |
| 2019-12-31 | HK$0.11 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | HK$1.90 B | 75.52% | 🇺🇸 USA |